Balance and Health-Related Quality of Life After 1 Year of COVID-19 Social Restriction Measures: A Cross-Sectional Study in Two Samples from Spain.

Publication date: Oct 30, 2024

The COVID-19 pandemic significantly impacted the well-being of the general population. However, more information is needed regarding the relationship between participation-related outcomes. This study aimed to analyze the impact of the pandemic on occupational balance (OB) and health-related quality of life (HRQoL) before and after social restrictions and to explore their relationship with COVID-19 diagnosis. We conducted a study among individuals diagnosed with COVID-19, assigning a healthy control group with the same sociodemographic characteristics using the EQ-5D-5L and the Occupational Balance Questionnaire (OBQ). The final sample size consisted of 61 participants in the COVID-19 diagnosis group (50. 8% male; mean age 34. 6 +/- 14. 17 years) and 57 healthy participants (50. 8% male; mean age 33. 7 +/- 13. 77 years). There were no differences in the sociodemographic variables between the groups. Significant differences were found between groups both before the pandemic and 1 year after confinement measures in HRQoL and OBQ (p < 0. 005). The regression model indicated significant associations (p < 0. 001) between HRQoL and both current OB and COVID-19 diagnosis. However, the OBQ scores from before the pandemic did not show a significant association with HRQoL (p = 0. 336). In conclusion, social restrictions from the COVID-19 pandemic negatively impacted HRQoL in our sample even 1 year after confinement, with COVID-19 diagnosis and occupational imbalance predicting worse outcomes, highlighting the need for targeted interventions not only for the current situation but also for possible future public health crises.

Open Access PDF

Concepts Keywords
Basel home lockdown
Healthcare occupational balance
Pandemic pandemic
Spain quality of life
social constraints

Semantics

Type Source Name
drug DRUGBANK Isoxaflutole
disease IDO quality
disease MESH COVID-19
drug DRUGBANK Coenzyme M
disease MESH uncertainty
disease MESH burnout
disease MESH anxiety
disease MESH depression
disease MESH post traumatic stress disorder
disease MESH lifestyles
disease IDO intervention
disease IDO process
drug DRUGBANK Trestolone

Original Article

(Visited 2 times, 1 visits today)